Cargando…
Safety and tolerability of dalcetrapib (RO4607381/JTT-705): results from a 48-week trial
AIMS: Co-primary objectives were to evaluate dalcetrapib (JTT-705/RO4607381), which targets cholesteryl ester transfer protein (CETP), effects on high-density lipoprotein cholesterol (HDL-C) in participants with coronary heart disease or risk equivalents and to evaluate potential changes in mesenter...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821630/ https://www.ncbi.nlm.nih.gov/pubmed/20097702 http://dx.doi.org/10.1093/eurheartj/ehp601 |